Are LNAI insiders buying or selling?

In the last 90 days, Lunai Bioworks (LNAI) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own LNAI?

See every hedge fund and asset manager holding Lunai Bioworks (LNAI).

How much of LNAI trades in dark pools?

Track Lunai Bioworks (LNAI) dark pool activity and off-exchange block trades.

Lunai Bioworks (LNAI) Stock — 47.3% Short — Squeeze Watch

Also trades as: RENB (NASDAQ) · $vol 0M

$1.30

-0.08 (-5.80%)

Weekly Expected Move ±12.4%

$1 $1 $1 $1 $2

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 27 · $5.9M mcap · 3M float · 27.98% daily turnover · Short 49% of daily vol

Smart Money Score

Watch 25

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$5.9M

52W Range1.208-13.28

Volume124,882

Avg Volume705,415

Beta0.34

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEODavid H. Weinstein

Employees29

SectorHealthcare

IndustryBiotechnology

IPO Date2025-09-30

Websitelunaibioworks.com

2080 Century Park East
Los Angeles, CA 90067
US

305 918 1980

About Lunai Bioworks Inc.

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Latest News